Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance use disorders and alleviate existing addictions, according to findings from a large study of U.S.

GLP-1 drugs like Ozempic, Wegovy, and Zepbound are prescribed for weight loss, diabetes, and blood-sugar management. But as more people use them, patients are reporting a decrease in cravings for ...

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) receptor ...

Researchers believe that GLP-1 drugs act on reward areas of the brain that are responsible for food cravings, making it possible that they silence cravings for addictive substances. The Conversation — ...

Weight-loss drugs such as Wegovy and Ozempic may become the new frontline warriors in treating and preventing drug and alcohol addiction, a large new study shows. The research, published Wednesday in ...

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...